Report: COVID-19 patients are responding quickly to experimental drug remdesivir


In Chicago, COVID-19 coronavirus patients participating in a clinical study of the antiviral medicine remdesivir are experiencing quick recoveries from their respiratory and fever symptoms, Stat News reported Thursday.
Remdesivir was developed by Gilead Sciences to treat Ebola. The company is conducting two global studies — the severe COVID-19 study includes 2,400 patients at 152 trial sites, and the moderate COVID-19 study has 1,600 patients at 169 sites. The trials are investigating five- and 10-day treatment courses of remdesivir, and aim to have a statistical comparison of improvement between them.
University of Chicago Medicine is one of the hospitals participating, with 125 COVID-19 patients — 113 of them with severe symptoms — taking part in two Phase 3 clinical trials, receiving daily infusions of remdesivir. Stat has obtained video of Kathleen Mullane, the University of Chicago's infectious disease specialist who is overseeing the studies, sharing with her colleagues updates on the trials, including how nearly all of the patients have been discharged in less than a week.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Only two patients have died, she said, and when the drug is started, "we see fever curves falling." Mullane also shared that people have "come off ventilators a day after starting therapy. So, in that realm, overall our patients have done very well." Most patients leave the hospital after six days, she added, "so that tells us duration of therapy doesn't have to be 10 days. We have very few that went out to 10 days, maybe three."
The hospital's trials do not include a placebo group, and Stat notes that it is "impossible to determine the full study results with any certainty. Still, no other clinical data from the Gilead studies have been released to date, and excitement is high." Read more at Stat News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
By Peter Weber, The Week US
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
By Peter Weber, The Week US
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US